Plasminogen activator inhibitor type 1 gene polymorphism and sepsis (Q33990846)

30 July 2017

1 reference

title

Plasminogen activator inhibitor type 1 gene polymorphism and sepsis (English)

1 reference

30 July 2017

0 references

1 reference

Jan A Hazelzet

2

0 references

author name string

P W M Hermans

series ordinal

1

1 reference

PubMed ID

16237647

30 July 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

Clinical Infectious Diseases

30 July 2017

1 reference

30 July 2017

41 Suppl 7

1 reference

30 July 2017

S453-8

1 reference

Plasminogen activator inhibitor 1 (PAI-1): in vitro activities and clinical relevance

30 July 2017

1 reference

Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential

21 January 2018

1 reference

CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression

21 January 2018

1 reference

Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia

21 January 2018

1 reference

Coagulation, fibrinolysis, and fibrin deposition in acute lung injury

21 January 2018

1 reference

Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock

21 January 2018

1 reference

Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study

21 January 2018

1 reference

Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk

21 January 2018

1 reference

Coagulation and fibrinolysis abnormalities in obesity

21 January 2018

1 reference

The insulin resistance syndrome: implications for thrombosis and cardiovascular disease

21 January 2018

1 reference

Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease

21 January 2018

1 reference

Angiotensin and vascular fibrinolytic balance

21 January 2018

1 reference

PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants.

21 January 2018

1 reference

Severity of Meningococcal Disease in Children and the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism

21 January 2018

1 reference

Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort.

21 January 2018

1 reference

Aging accelerates endotoxin-induced thrombosis : increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging

21 January 2018

1 reference

Plasminogen-activator inhibitor type 1 and coronary artery disease

21 January 2018

1 reference

Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney

21 January 2018

1 reference

Plasminogen activator inhibitor-1 in the pathogenesis of asthma

21 January 2018

1 reference

Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury.

21 January 2018

1 reference

The plasminogen activator system: biology and regulation

21 January 2018

1 reference

Crosstalk between inflammation and thrombosis

21 January 2018

1 reference

Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades.

21 January 2018

1 reference

Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients

21 January 2018

1 reference

Disseminated intravascular coagulation in trauma patients

21 January 2018

1 reference

Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis

21 January 2018

1 reference

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction

21 January 2018

1 reference

4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease

21 January 2018

1 reference

Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children*

21 January 2018

1 reference

The haematological manifestations of sepsis

21 January 2018

1 reference

The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia

21 January 2018

1 reference

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: A retrospective study*

21 January 2018

1 reference

Endothelial protein C activation in meningococcal sepsis

21 January 2018

1 reference

Inhibition of PAI-1: a new anti-thrombotic approach

21 January 2018

1 reference

Plasminogen Activator Inhibitor 1 Expression is Regulated by the Inflammatory Mediators Interleukin-1α, Tumor Necrosis Factor-α, Transforming Growth Factor-β and Oncostatin M in Human Cardiac Myocytes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/431996

1 reference

30 July 2017

1 reference

PubMed ID

16237647